FERMT3 and colorectal carcinoma: Fermitin family member 3 (FERMT3) promoted the blockage of PD-L1 by FERMT3-mediated Wnt/β-catenin signalling to suppress CRC cell invasion, 5-FU resistance and NK cells-mediated tumour killing [196].